Krishna Yeshwant
InvestorFounderManaging Partner at GV (Google Ventures) · Board director at Verve Therapeutics · Board director at PatientPing · Board director at Element Science
Boston, Massachusetts
Writes $250K – $50M checks · typically $25M
About
Krishna Yeshwant maintains an active clinical practice at Brigham and Women's Hospital, brings Google's early business development experience, spans biology to patient-facing software, and champions new long-horizon science funding models.
Likely email· guessed from name + firm domain, not firm-published
- k•••@gv.comreveal75% confident
Invests in
AI & Machine LearningBiotechConsumerDigital HealthEnterprise SoftwareHealthtechMedical Devices
Beyond investing
- Founded
- Yeshwant helped launch an electronic data interchange startup that was acquired by Hewlett-Packard. Yeshwant helped launch a network security firm that was purchased by Symantec.
- Education
- Studied at Harvard Medical School (MD) Studied at Harvard Business School (MBA) Studied at Stanford University (BS, Computer Science)
- More
- Yeshwant established an incubation program at GV that launched ROME Therapeutics and Verve Therapeutics.
From Krishna's own website — common ground for a warm intro.
Board director at Verve Therapeutics
Intro paths
In turn, Krishna can intro founders to Verve Therapeutics's investors below.
Verve Therapeutics's investors · 6
Co-founders at Verve Therapeutics
Board director at PatientPing
Intro paths
In turn, Krishna can intro founders to PatientPing's investors below.
PatientPing's investors · 4
Co-founders at PatientPing
Board director at Element Science
Intro paths
In turn, Krishna can intro founders to Element Science's investors below.
Element Science's investors · 3
Co-founders at Element Science
Experience
- Partners HealthCareAttendingcurrent2009 — present
- GVPartnercurrent2009 — present
- GoogleNew Business Development2008 — 2009
Education
- Harvard Business SchoolMBA2007 — 2009
- Harvard Medical SchoolDoctor of Medicine (MD)2004 — 2009
- IMSA
- Stanford University
Skills & more
From Krishna's professional profile.
Deals · 10
FogpharmaBoard seat
via GV (Google Ventures) · filed Dec 2022 · $178M raise
Spotlight TherapeuticsBoard seat
via GV (Google Ventures) · filed Jan 2022 · $65M raise
Quartet HealthBoard seat
via GV (Google Ventures) · filed Dec 2021 · $120M raise
LifeMine TherapeuticsBoard seat
via GV (Google Ventures) · filed Mar 2019 · $70.1M raise
1Life HealthcareBoard seat
via GV (Google Ventures) · filed Sep 2018 · $250M raise
Element ScienceBoard seat
via GV (Google Ventures) · filed Aug 2016 · $25M raise
PatientPingBoard seat
via GV (Google Ventures) · filed Nov 2015 · $9.7M raise
DnanexusBoard seat
via GV (Google Ventures) · filed Apr 2015 · $15M raise
InsitroLed round
via GV (Google Ventures) · filed Mar 2020
Flatiron HealthLed round
via GV (Google Ventures) · filed Oct 2012
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
AledadeBeam TherapeuticsFoundation MedicineOne Medical
Board seats
Investor
Ankyra TherapeuticsAspen NeuroscienceCala HealthClear LabsClover HealthCounsel HealthCurie.BioEQRxFreenomeGate BioscienceGRAILGuide TherapeuticsHyperfine ResearchImagenInfinitusInfinitus SystemsInvetxMonte Rosa TherapeuticsRelay TherapeuticsROME TherapeuticsThatchVerilyVerve Therapeutics
Sources: the firm's website · curated public sources · SEC Form D filings.
Colleagues at GV (Google Ventures)
Network2
Investors connected to Krishna in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Krishna Yeshwant?
- Krishna Yeshwant maintains an active clinical practice at Brigham and Women's Hospital, brings Google's early business development experience, spans biology to patient-facing software, and champions new long-horizon science funding models.
- Where does Krishna Yeshwant work?
- Krishna Yeshwant is Managing Partner at GV (Google Ventures) and Board director at Verve Therapeutics and Board director at PatientPing and Board director at Element Science.
- What does Krishna Yeshwant invest in?
- Krishna Yeshwant invests in AI & Machine Learning, Biotech, Consumer, Digital Health, Enterprise Software, Healthtech, Medical Devices.
- What check size does Krishna Yeshwant write?
- Krishna Yeshwant typically writes checks of $250K – $50M.
- What boards does Krishna Yeshwant sit on?
- Krishna Yeshwant holds tracked board seats at 1Life Healthcare, Dnanexus, Element Science, Fogpharma, LifeMine Therapeutics, PatientPing, Quartet Health, Quartet Health, Spotlight Therapeutics, Verve Therapeutics.
- What companies has Krishna Yeshwant invested in?
- Investments tracked here include Aledade, Beam Therapeutics, Flatiron Health, Foundation Medicine, Insitro, One Medical, Ankyra Therapeutics, Aspen Neuroscience, Cala Health, Clear Labs, Clover Health, Counsel Health, and 20 more.
- Where did Krishna Yeshwant go to school?
- Krishna Yeshwant studied at Harvard Business School (MBA); Harvard Medical School (Doctor of Medicine (MD)); IMSA.
- Does Krishna Yeshwant lead rounds?
- Yes — Krishna Yeshwant has led 6 tracked investments.
Same school
Also attended Harvard Business School1,977
+ 1,971 more
Also attended Harvard Medical School135
.png)
+ 129 more
Also attended Stanford University2,000
+ 1,994 more
Shared employers
Also worked at Google1,595
+ 1,589 more